13.01.2011 • News

Thermo Fisher To Pursue Sale Of Lab-Testing Units

Thermo Fisher Scientific, a maker of scientific instruments, is pursuing a sale of two lab-testing divisions that may fetch up to $1 billion, Bloomberg said, citing three people familiar with the matter.

Thermo Fisher has hired Goldman Sachs to handle the sale of Athena Diagnostics, which may be sold for $600-$700 million, and Barclays Capital to help it sell Lancaster Labs, which may fetch $200-$300 million, Bloomberg said.

In December, Thermo Fisher agreed to buy Dionex Corp for $2.1 billion to broaden its lab equipment and environmental safety offerings and boost its presence in Asia.

Thermo Fisher was not immediately available for comment outside of regular U.S. business hours.

Company

Logo:

Thermo Fisher Scientific

81 Wyman Street
02454 Waltham, MA
US

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.